Core Scientific (CORZ) Net Cash Flow (2021 - 2026)

Core Scientific has disclosed Net Cash Flow across 6 years of filings, most recently posting $834.6 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at $834.6 million, up 703.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $447.3 million (down 23.47% YoY), and the FY2025 annual result was -$525.6 million, down 168.5% from the prior year.
• Net Cash Flow came in at $834.6 million for Q1 2026 at Core Scientific, up from -$142.1 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $834.6 million in Q1 2026 to a low of -$142.1 million in Q4 2025.
• The 5-year median for Net Cash Flow is $5.8 million (2023), against an average of $59.7 million.
• Across the five-year window, Net Cash Flow soared 10014.08% in 2024 and tumbled 583.59% in 2025, its largest moves.
• Core Scientific's Net Cash Flow stood at $14.6 million in 2022, then slumped by 60.5% to $5.8 million in 2023, then jumped by 10014.08% to $583.2 million in 2024, then slumped by 124.36% to -$142.1 million in 2025, then jumped by 687.48% to $834.6 million in 2026.
• The last three Net Cash Flow figures came in at $834.6 million (Q1 2026), -$142.1 million (Q4 2025), and -$127.9 million (Q3 2025), per Business Quant data.